Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:29 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1CompletedINTERVENTIONAL

Post-Stroke Improvement of Motor Function

ClinicalTrials.gov · NCT03543917 · Registry updated: 2018-11-19

Condition / research focus: Cerebrovascular Accident
Sponsor: Fundatia Bio-Forum
Countries with listed sites: Romania
Registry dates and results: Start: 2017-08-08. Completion: 2018-09-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Perfusion with New Combination Medication (combination_product)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Fundatia Bio-Forum
Bucharest, Bucharest, Romania
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intramuscular Oxytocics: A Randomised Control Trial

ClinicalTrials.gov · NCT02216383 · Registry updated: 2018-11-14

Condition / research focus: Post Partum Haemorrhage
Sponsor: North Bristol NHS Trust
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2015-02. Completion: 2018-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Syntocinon (drug) — also listed as: Oxytocin
Syntometrine (drug) — also listed as: Syntometrine 500 micrograms/5 IU Solution for Injection

Where the study takes place — 5 listed sites

North Bristol NHS Trust
Bristol, Avon, United Kingdom
Site recruitment: Not reported
Gloucestershire Hospitals NHS Trust
Gloucester, Gloucestershire, United Kingdom
Site recruitment: Not reported
Royal United Hospital NHS Trust
Bath, Somerset, United Kingdom
Site recruitment: Not reported
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
Site recruitment: Not reported
Great Western Hospital
Swindon, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety

ClinicalTrials.gov · NCT03085654 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-03-03. Completion: 2018-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Oxytocin treatment
Placebo nasal spray (drug) — also listed as: Placebo control

Where the study takes place — 1 listed sites

school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effects of Oxytocin on Affective Touch

ClinicalTrials.gov · NCT03282162 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-08-28. Completion: 2018-07-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses

ClinicalTrials.gov · NCT03610919 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2018-03-01. Completion: 2018-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nasal Sprays (drug)

Where the study takes place — 1 listed sites

school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Effects of Intranasal Oxytocin on Emotion Regulation

ClinicalTrials.gov · NCT03055546 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-02. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug) — also listed as: Intranasal Placebo

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin Modulates Eye Gaze Behavior During Social Processing

ClinicalTrials.gov · NCT03293511 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-06-09. Completion: 2019-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 2 listed sites

school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting
University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Does Oxytocin Modulate Rewarding Effects in Women and Fluctuating Across the Menstrual Cycle

ClinicalTrials.gov · NCT03144115 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-10. Completion: 2018-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: oxytocin treatment
Placebos (drug) — also listed as: placebo control

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of Chia
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effects of Oxytocin on Social Touch

ClinicalTrials.gov · NCT03278860 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-08-28. Completion: 2019-10 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug)
intranasal placebo (drug)
intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study

ClinicalTrials.gov · NCT02741063 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-05. Completion: 2019-09 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

screen low autistic subjects (behavioral)
screen high autistic subjects (behavioral)
oxytocin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

China, Sichuan
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin's Effect on Attention Training

ClinicalTrials.gov · NCT03128242 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-11-25. Completion: 2018-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Membrane Sweeping Versus Transcervical Foley Catheter for Induction of Labour in Women With Previous Caesarean Delivery

ClinicalTrials.gov · NCT03326557 · Registry updated: 2018-10-17

Condition / research focus: Labour, Induced; Vaginal Birth After Caesarean
Sponsor: Ministry of Health, Malaysia
Countries with listed sites: Malaysia
Registry dates and results: Start: 2018-02-15. Completion: 2018-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Membrane Sweeping versus Transcervical Foley Catheter for Induction of Labour in Women with Previous Caesarean Delivery (procedure)

Where the study takes place — 1 listed sites

Sibu Hospital
Sibu, Sarawak, Malaysia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Can Oxytocin Enhance the Placebo Effect?

ClinicalTrials.gov · NCT02745522 · Registry updated: 2018-10-15

Condition / research focus: Oxytocin Effect on Memory Performance During Phase 1; Oxytocin Effect on Memory Performance During Phase 2; Oxytocin Effect on Memory Performance During Phase 3; Oxytocin Effect on Memory Performance During Phase 4
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2015-12. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin for Couples Conflict Resolution

ClinicalTrials.gov · NCT02941692 · Registry updated: 2018-10-12

Condition / research focus: Substance Misuse; Interpersonal Conflict; Neuroendocrine Reactivity
Sponsor: Medical University of South Carolina
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06. Completion: 2017-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Oxytocin Infusion and Abdominal Myomectomy

ClinicalTrials.gov · NCT03702946 · Registry updated: 2018-10-11

Condition / research focus: Oxytocin and Abdominal Myomectomy
Sponsor: Armed Forces Hospital, Pakistan
Countries with listed sites: Pakistan
Registry dates and results: Start: 2017-07-15. Completion: 2018-01-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin in abdominal myomectomy (other)

Where the study takes place — 2 listed sites

Department of Pediatrics
Rawalpindi, Punjab Province, Pakistan
Site recruitment: Not reported
Military Hospital
Rawalpindi, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

FOLCROM Trial: Foley Catheter in Rupture of Membranes

ClinicalTrials.gov · NCT01973036 · Registry updated: 2018-09-24

Condition / research focus: Premature Rupture of Membranes
Sponsor: Geisinger Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2014-03. Completion: 2016-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Foley Catheter (device) — also listed as: 30cc/16 French
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 5 listed sites

Banner Good Samaritan Regional Medical Center
Phoenix, Arizona, United States
Site recruitment: Not reported
Christiana Care Health System CCHS
Newark, Delaware, United States
Site recruitment: Not reported
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
Site recruitment: Not reported
Geisinger Medical Center
Danville, Pennsylvania, United States
Site recruitment: Not reported
Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers

ClinicalTrials.gov · NCT02257359 · Registry updated: 2018-09-13

Condition / research focus: Embryo Transfer
Sponsor: GlaxoSmithKline
Countries with listed sites: United States
Registry dates and results: Start: 2014-12-18. Completion: 2015-01-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Epelsiban (drug)

Where the study takes place — 1 listed sites

GSK Investigational Site
Overland Park, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers

ClinicalTrials.gov · NCT02703181 · Registry updated: 2018-09-13

Condition / research focus: Embryo Transfer
Sponsor: GlaxoSmithKline
Countries with listed sites: United States
Registry dates and results: Start: 2015-07-09. Completion: 2015-09-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Epelsiban (GSK557296) (drug)
Placebo to match GSK557296 (drug)

Where the study takes place — 1 listed sites

GSK Investigational Site
Overland Park, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Implementation of AFL Monitoring in Clinical Use

ClinicalTrials.gov · NCT03650972 · Registry updated: 2018-08-29

Condition / research focus: Labour Dystocia
Sponsor: Turku University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2018-09-15. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Samarin (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon

ClinicalTrials.gov · NCT01139801 · Registry updated: 2018-08-24

Condition / research focus: Induction of Labor
Sponsor: Aultman Health Foundation
Countries with listed sites: United States
Registry dates and results: Start: 2009-09. Completion: 2010-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Misoprostol (drug) — also listed as: cytotec

Where the study takes place — 1 listed sites

Aultman Health Foundation
Canton, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:29 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1CompletedINTERVENTIONAL

Post-Stroke Improvement of Motor Function

ClinicalTrials.gov · NCT03543917 · Registry updated: 2018-11-19

Condition / research focus: Cerebrovascular Accident
Sponsor: Fundatia Bio-Forum
Countries with listed sites: Romania
Registry dates and results: Start: 2017-08-08. Completion: 2018-09-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Perfusion with New Combination Medication (combination_product)

Where the study takes place — 1 listed sites

Fundatia Bio-Forum
Bucharest, Bucharest, Romania
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intramuscular Oxytocics: A Randomised Control Trial

ClinicalTrials.gov · NCT02216383 · Registry updated: 2018-11-14

Condition / research focus: Post Partum Haemorrhage
Sponsor: North Bristol NHS Trust
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2015-02. Completion: 2018-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Syntocinon (drug) — also listed as: Oxytocin
Syntometrine (drug) — also listed as: Syntometrine 500 micrograms/5 IU Solution for Injection

Where the study takes place — 5 listed sites

North Bristol NHS Trust
Bristol, Avon, United Kingdom
Site recruitment: Not reported
Gloucestershire Hospitals NHS Trust
Gloucester, Gloucestershire, United Kingdom
Site recruitment: Not reported
Royal United Hospital NHS Trust
Bath, Somerset, United Kingdom
Site recruitment: Not reported
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
Site recruitment: Not reported
Great Western Hospital
Swindon, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety

ClinicalTrials.gov · NCT03085654 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-03-03. Completion: 2018-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Oxytocin treatment
Placebo nasal spray (drug) — also listed as: Placebo control

Where the study takes place — 1 listed sites

school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effects of Oxytocin on Affective Touch

ClinicalTrials.gov · NCT03282162 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-08-28. Completion: 2018-07-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses

ClinicalTrials.gov · NCT03610919 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2018-03-01. Completion: 2018-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nasal Sprays (drug)

Where the study takes place — 1 listed sites

school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Effects of Intranasal Oxytocin on Emotion Regulation

ClinicalTrials.gov · NCT03055546 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-02. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug) — also listed as: Intranasal Placebo

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin Modulates Eye Gaze Behavior During Social Processing

ClinicalTrials.gov · NCT03293511 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-06-09. Completion: 2019-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 2 listed sites

school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting
University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Does Oxytocin Modulate Rewarding Effects in Women and Fluctuating Across the Menstrual Cycle

ClinicalTrials.gov · NCT03144115 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-10. Completion: 2018-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: oxytocin treatment
Placebos (drug) — also listed as: placebo control

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of Chia
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effects of Oxytocin on Social Touch

ClinicalTrials.gov · NCT03278860 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2017-08-28. Completion: 2019-10 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug)
intranasal placebo (drug)
intranasal oxytocin (drug)
intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study

ClinicalTrials.gov · NCT02741063 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-05. Completion: 2019-09 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

screen low autistic subjects (behavioral)
screen high autistic subjects (behavioral)
oxytocin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

China, Sichuan
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin's Effect on Attention Training

ClinicalTrials.gov · NCT03128242 · Registry updated: 2018-10-29

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-11-25. Completion: 2018-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Membrane Sweeping Versus Transcervical Foley Catheter for Induction of Labour in Women With Previous Caesarean Delivery

ClinicalTrials.gov · NCT03326557 · Registry updated: 2018-10-17

Condition / research focus: Labour, Induced; Vaginal Birth After Caesarean
Sponsor: Ministry of Health, Malaysia
Countries with listed sites: Malaysia
Registry dates and results: Start: 2018-02-15. Completion: 2018-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Membrane Sweeping versus Transcervical Foley Catheter for Induction of Labour in Women with Previous Caesarean Delivery (procedure)

Where the study takes place — 1 listed sites

Sibu Hospital
Sibu, Sarawak, Malaysia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Can Oxytocin Enhance the Placebo Effect?

ClinicalTrials.gov · NCT02745522 · Registry updated: 2018-10-15

Condition / research focus: Oxytocin Effect on Memory Performance During Phase 1; Oxytocin Effect on Memory Performance During Phase 2; Oxytocin Effect on Memory Performance During Phase 3; Oxytocin Effect on Memory Performance During Phase 4
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2015-12. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin for Couples Conflict Resolution

ClinicalTrials.gov · NCT02941692 · Registry updated: 2018-10-12

Condition / research focus: Substance Misuse; Interpersonal Conflict; Neuroendocrine Reactivity
Sponsor: Medical University of South Carolina
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06. Completion: 2017-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Oxytocin Infusion and Abdominal Myomectomy

ClinicalTrials.gov · NCT03702946 · Registry updated: 2018-10-11

Condition / research focus: Oxytocin and Abdominal Myomectomy
Sponsor: Armed Forces Hospital, Pakistan
Countries with listed sites: Pakistan
Registry dates and results: Start: 2017-07-15. Completion: 2018-01-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin in abdominal myomectomy (other)

Where the study takes place — 2 listed sites

Department of Pediatrics
Rawalpindi, Punjab Province, Pakistan
Site recruitment: Not reported
Military Hospital
Rawalpindi, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

FOLCROM Trial: Foley Catheter in Rupture of Membranes

ClinicalTrials.gov · NCT01973036 · Registry updated: 2018-09-24

Condition / research focus: Premature Rupture of Membranes
Sponsor: Geisinger Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2014-03. Completion: 2016-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Foley Catheter (device) — also listed as: 30cc/16 French
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 5 listed sites

Banner Good Samaritan Regional Medical Center
Phoenix, Arizona, United States
Site recruitment: Not reported
Christiana Care Health System CCHS
Newark, Delaware, United States
Site recruitment: Not reported
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
Site recruitment: Not reported
Geisinger Medical Center
Danville, Pennsylvania, United States
Site recruitment: Not reported
Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers

ClinicalTrials.gov · NCT02257359 · Registry updated: 2018-09-13

Condition / research focus: Embryo Transfer
Sponsor: GlaxoSmithKline
Countries with listed sites: United States
Registry dates and results: Start: 2014-12-18. Completion: 2015-01-29 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Epelsiban (drug)

Where the study takes place — 1 listed sites

GSK Investigational Site
Overland Park, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers

ClinicalTrials.gov · NCT02703181 · Registry updated: 2018-09-13

Condition / research focus: Embryo Transfer
Sponsor: GlaxoSmithKline
Countries with listed sites: United States
Registry dates and results: Start: 2015-07-09. Completion: 2015-09-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Epelsiban (GSK557296) (drug)
Placebo to match GSK557296 (drug)

Where the study takes place — 1 listed sites

GSK Investigational Site
Overland Park, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Implementation of AFL Monitoring in Clinical Use

ClinicalTrials.gov · NCT03650972 · Registry updated: 2018-08-29

Condition / research focus: Labour Dystocia
Sponsor: Turku University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2018-09-15. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Samarin (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon

ClinicalTrials.gov · NCT01139801 · Registry updated: 2018-08-24

Condition / research focus: Induction of Labor
Sponsor: Aultman Health Foundation
Countries with listed sites: United States
Registry dates and results: Start: 2009-09. Completion: 2010-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Misoprostol (drug) — also listed as: cytotec

Where the study takes place — 1 listed sites

Aultman Health Foundation
Canton, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →